Evidence in animal health & agrifood.
Microbiome, disease-sensing and parasitology applications spanning livestock, companion and performance animals — labelled by its actual evidence status.
GALEN microbiome intelligence
Microbiome sequence data engineered into a nutrition and health decision loop, cutting biome-analysis turnaround from the traditional 4–6 weeks to 24–48 hours, in active use across livestock and performance-animal health programmes.
On-farm disease sensing
Sensor fusion engineered for early disease-risk detection and intervention timing, live and in active use on-farm.
Automated parasitology imaging
Chiron automates faecal egg counting and parasite-motility analysis from image and video samples, replacing slow manual microscopy as rising anthelmintic resistance drives demand for faster parasitology pipelines. It has dramatically changed how assays are graded — moving manual, subjective scoring onto a fine-tuned model that grades on a 0–100 scale, and includes a unique model Agxio developed to measure peristalsis. Agxio⋅Intelligence powers the underlying grading models, with Agxio⋅Cognition applied for interpretable, review-ready output.
Bionanotechnology framework for Johne’s disease
Agxio developed a bionanotechnology beta framework to address Johne’s disease in animals — a chronic, hard-to-detect mycobacterial infection with major herd-health and economic impact. Agxio⋅Intelligence models the relationship between nanotechnology-derived biomarker signals and infection stage, while Agxio⋅Cognition turns those signals into a defensible, review-ready diagnostic read-out.
We label every result by its actual status — historical demonstration, completed programme, pilot or evaluation, beta, product capability, or live deployment — and update labels as work progresses. We do not present a benchmark result as a production outcome, a beta as a finished product, or a pilot as a deployment.
Want the detail behind a result?
We’re glad to walk through methodology, data provenance and evaluation design for any case here.
Discuss a high-value use case